AiCure Raises $16M+ for R&D and Operations Expansion, Bolstering Its Leading Role in AI-Driven Clinical Trials.
AiCure is an AI and advanced data analytics company that focuses on improving patient engagement and sponsor insights in clinical trials.
Company Name: AiCure
Location: NYC, USA
Sector: AI and Data Analytics in Clinical Trials
Funding Details: Secured $12M in loan refinancing and raised an additional $4M+ from existing investors.
Purpose of Investment: To invest in research and development, expand operations, and enhance AiCure's products and services.
About Company: AiCure is an AI and advanced data analytics company that focuses on improving patient engagement and sponsor insights in clinical trials. The company’s technology is a significant contributor to advancements in the life sciences industry.
Recent Achievements:
- Received seven new US patents in 2023, bringing the total US patent count to 86, with additional international patents.
- These patents enhance AiCure's digital biomarker solutions and support its core business.
New Leadership Appointments:
- Sondra Pepe, Senior Vice President of Product Management: Brings nearly 20 years of experience in eClinical SaaS technology. Responsible for overseeing product direction, management, and delivery at AiCure.
- Josh Wilson, Senior Vice President of Operations: With extensive experience at Syneos Health and INC Research, he oversees the operations teams for the delivery of AiCure’s platform and site services.
